Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today.
Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis, sales growth was 32.9%.
On a GAAP basis, net earnings more than doubled to $1.79 billion, or $1.00 per share, compared to the year-ago period. Adjusted EPS jumped 103% to $1.32.
For FY2021, Abbott projects GAAP EPS from continuing operations to be at least $3.74. Adjusted EPS from continuing operations is expected to be at least $5.00.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a
